Sun Pharma completes acquisition of US InSite Vision

Chennai, Nov 3 (IANS) Sun Pharmaceutical Industries Ltd on Tuesday said it has successfully completed the acquisition of US based ophthalmic drug maker InSite Vision Inc.

In a statement, Sun Pharma said the acquisition was completed by means of a short-form merger under Delaware law.

Post the short-form merger, Insite has become an indirect wholly owned subsidiary of Sun Pharma, the statement added.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here